Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Profiling of Carnitine Shuttle System Intermediates in Gliomas Using Solid-Phase Microextraction (SPME).

Molecules (Basel, Switzerland) - 10 Oct 2021

Bogusiewicz Joanna, Burlikowska Katarzyna, Jaroch Karol, Gorynska Paulina Zofia, Gorynski Krzysztof, Birski Marcin, Furtak Jacek, Paczkowski Dariusz, Harat Marek, Bojko Barbara

Abstract excerpt

Alterations in the carnitine shuttle system may be an indication of the presence of cancer. As such, in-depth analyses of this pathway in different malignant tumors could be important for the detection and treatment of this disease. The current study aims to assess the profiles of carnitine and acylcarnitines in gliomas with respect to their grade, the presence of isocitrate dehydrogenase (IDH) mutations, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carnitine

Share to Chromosome Aberrations

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Neoplasm Staging

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 34684691
DOI: 10.3390/molecules26206112
PMCID: PMC8540799

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Profiling of Carnitine Shuttle System Intermediates in Gliomas Using Solid-Phase Microextraction (SPME).PMID 34684691Read ↗

Investigating the Potential Use of Chemical Biopsy Devices to Characterize Brain Tumor Lipidomes.Semantic proximity Read ↗

Targeted metabolic profiling in determining the metabolic heterogeneity in human biopsies of different grades of gliomaSemantic proximity Read ↗

The genomic alterations in glioblastoma influence the levels of CSF metabolites.Semantic proximity Read ↗

Distinct metabolic hallmarks of WHO classified adult glioma subtypes.Semantic proximity Read ↗

Methodological Approaches for Assessing Metabolomic Changes in Glioblastomas.Semantic proximity Read ↗

Association between altered metabolism and genetic mutations in human glioma.Semantic proximity Read ↗

Glioblastoma multiforme: Metabolic differences to peritumoral tissue and IDH-mutated gliomas revealed by mass spectrometry imaging.Semantic proximity Read ↗

Malignancy-associated metabolic profiling of human glioma cell lines using 1H NMR spectroscopySemantic proximity Read ↗

Altered Expression of Carnitine Palmitoyl Transferase 1C (CPT1C) is Related to the Aggressive Pathobiology of Glioblastoma: A Potential Metabolic VulnerabilitySemantic proximity Read ↗

Intraoperative detection of isocitrate dehydrogenase mutations in human gliomas using a miniature mass spectrometer.Semantic proximity Read ↗

Intraoperative Mass Spectrometry Platform for IDH Mutation Status Prediction, Glioma Diagnosis, and Estimation of Tumor Cell Infiltration.Semantic proximity Read ↗

Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative updateSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.